Alkem Laboratories Limited
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective… Read more
Alkem Laboratories Limited (ALKEM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.061x
Based on the latest financial reports, Alkem Laboratories Limited (ALKEM) has a cash flow conversion efficiency ratio of 0.061x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹8.37 Billion) by net assets (₹138.11 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Alkem Laboratories Limited - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Alkem Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Alkem Laboratories Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alkem Laboratories Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Turkiye Sise ve Cam Fabrikalari AS
OTCGREY:TKKYY
|
0.040x |
|
The Scotts Miracle-Gro Company
F:SCQA
|
-2.659x |
|
Petronet LNG Limited
NSE:PETRONET
|
0.086x |
|
APT Medical Inc
SHG:688617
|
0.077x |
|
SmartSens Technology (Shanghai) Co. Ltd. A
SHG:688213
|
N/A |
|
Anker Innovations Technology Co Ltd
SHE:300866
|
0.044x |
|
Trinity Industries Inc
NYSE:TRN
|
0.035x |
|
TOHO GAS CO. LTD
F:59W
|
N/A |
Annual Cash Flow Conversion Efficiency for Alkem Laboratories Limited (2010–2025)
The table below shows the annual cash flow conversion efficiency of Alkem Laboratories Limited from 2010 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹124.34 Billion | ₹19.13 Billion | 0.154x | -15.39% |
| 2024-03-31 | ₹107.14 Billion | ₹19.48 Billion | 0.182x | +1.96% |
| 2023-03-31 | ₹94.35 Billion | ₹16.82 Billion | 0.178x | +42.00% |
| 2022-03-31 | ₹88.47 Billion | ₹11.11 Billion | 0.126x | -24.97% |
| 2021-03-31 | ₹75.58 Billion | ₹12.65 Billion | 0.167x | +80.46% |
| 2020-03-31 | ₹63.09 Billion | ₹5.85 Billion | 0.093x | -33.53% |
| 2019-03-31 | ₹55.72 Billion | ₹7.77 Billion | 0.140x | +151.85% |
| 2018-03-31 | ₹49.85 Billion | ₹2.76 Billion | 0.055x | -46.11% |
| 2017-03-31 | ₹45.83 Billion | ₹4.71 Billion | 0.103x | -46.36% |
| 2016-03-31 | ₹37.87 Billion | ₹7.26 Billion | 0.192x | +81.66% |
| 2015-03-31 | ₹30.85 Billion | ₹3.25 Billion | 0.106x | -3.41% |
| 2014-03-31 | ₹26.55 Billion | ₹2.90 Billion | 0.109x | +65.86% |
| 2013-03-31 | ₹23.74 Billion | ₹1.56 Billion | 0.066x | +5.93% |
| 2012-03-31 | ₹19.06 Billion | ₹1.18 Billion | 0.062x | -91.34% |
| 2011-03-31 | ₹11.67 Billion | ₹8.38 Billion | 0.718x | +1128.81% |
| 2010-03-31 | ₹12.05 Billion | ₹-840.93 Million | -0.070x | -- |